ProductNum | picture | CAS No. | Name and description | Formula | Quick order |
---|---|---|---|---|---|
HL1758 |
|
41060-16-6 |
Skullcapflavone I | Panicolin 98+% |
C17H14O6 | |
HL1752 |
|
508-71-4 |
Rosenonolactone 98+% |
C20H28O3 | |
CL2056 |
|
361442-04-8 |
Saxagliptin | BMS-477118 98+% |
C18H25N3O2 | |
CL1855A |
|
654671-78-0 |
Sitagliptin phosphate | MK-0431 phosphate 98+% |
C16H15F6N5O·H3O4P | |
HL1671 |
|
96574-01-5 |
Salvianolic acid A | Dan Phenolic Acid A | (+)-Salvianolic Acid A 98+% |
C26H22O10 | |
HL1652 |
|
48236-96-0 |
TetrahydroaMentoflavone 98+% |
C30H22O10 | |
HL1634 |
|
21401-21-8 |
Taxiphyllin 98+% |
C14H17NO7 | |
CL2860A |
|
149682-77-9 |
Talabostat | Val-boroPro | PT100 98+% |
C9H19BN2O3 | |
CL2860 |
|
150080-09-4 |
Talabostat Mesylate | Val-boroPro mesylate | PT100 mesylate 98+% |
C10H23BN2O6S | |
CL2746 |
|
2189684-44-2 |
Lenacapavir |GS-6207 98+% |
C39H32ClF10N7O5S2 | |
CL2712 |
|
906093-29-6 |
Teneligliptin hydrobromide ( MP-513 hydrobromide) 98+% |
C44H65Br5N12O2S2 | |
CL2706 |
|
668270-12-0 |
Linagliptin (BI 1356) 98+% |
C25H28N8O2 | |
CL1855B |
|
654671-77-9 |
Sitagliptin Phosphate Monohydrate 98+% |
C16H20F6N5O6P | |
CL2404A |
|
872728-81-9 |
Dabigatran etexilate mesylate 98+% |
C34H41N7O5 | |
CL2404 |
|
211915-06-9 |
Dabigatran etexilate; BIBR 1048 98+% |
C34H41N7O5 | |
CLA1291 |
|
1188277-05-5 |
Flanvotumab (Anti-TRP1 / TYRP1) 95+% |
— | |
CL2007 |
|
315-30-0 |
Allopurinol 98+% |
C5H4N4O | |
CL1972 |
|
314045-39-1 |
BPTES 98+% |
C24H24N6O2S3 | |
CL1414A |
|
1374639-74-3 |
Gemigliptin Tartrate 98+% |
C22H25F8N5O8 | |
CL1682 |
|
30827-99-7 |
AEBSF HCl | AEBSF hydrochloride | 4-(2-Aminoethyl)benzenesulfonylfluoride hydrochloride | 4-(2-Aminoethyl)benzenesulfonyl Fluoride Hydrochloride 98+% |
C8H11ClFNO2S | |